Johnson & Johnson (JNJ) plans to separate its Consumer Health business into a new publicly-traded company. With this move, JNJ aims to better position the companies to offer improved healthcare through innovation, boost growth and pursue targeted business strategies. The New Jersey-based healthcare giant’s shares closed 1.2% up on Friday at $165.01. The stock opened in green during the pre-market trading session on Monday. Plan Details Following the separation, Alex Gorsky will serve as Executive Chairman of Johnson & Johnson, while Joaquin Duato, the Vice-Chairman of the company’s Executive Committee, will become the CEO, effective January 3, 2022.
https://www.tipranks.com/news/johnson-johnson-to-separate-consumer-health-business-into-new-company?utm_source=advfn.com&utm_medium=referral
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Dec 2021 to Jan 2022 Click Here for more Johnson and Johnson Charts.
Johnson and Johnson (NYSE:JNJ)
Historical Stock Chart
From Jan 2021 to Jan 2022 Click Here for more Johnson and Johnson Charts.